Literatur

[1] Lo YM et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 1998; 339:1734

[2] Legler TJ et al. Prenatal RhD Testing: A review of studies published from 2006 to 2008. Transfus Med Hemother 2009; 36:189

[3] Clausen FB et al. Routine noninvasive prenatal screening for fetal RHD in plasma of RhD-negative pregnant women-2 years of screening experience from Denmark. Prenat Diagn 2014; 34:1000

[4] de Haas M et al. Sensitivity of fetal RHD screening for safe guidance of targeted anti-D immunoglobulin prophylaxis: prospective cohort study of a nationwide programme in the Netherlands. BMJ 2016; 355:i5789

[5] Müller SP et al. The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible. Transfusion 2008; 48:2292

[6] Harasim T, Klein HG. Nicht-invasive Pränataltestung (NIPT): Leistungsfähiges Verfahren ohne Eingriffsrisiko. Trillium Diagnostik 2016; 14(4):286–8